ArticleFrontiers in public health2026
Unveiling the non-linear synergistic effects of smoking and aging on cataract-AMD comorbidity: an explainable artificial intelligence approach.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The comorbidity of cataract and age-related macular degeneration (AMD) poses a significant public health burden. Traditional linear statistical models often fail to capture complex, non-linear interactions among risk factors. This study aimed to develop an interpretable machine learning framework to predict comorbidity risk and elucidate the synergistic effects of systemic and ocular factors. Methods: A retrospective case-control study was conducted involving 640 participants (264 comorbidity cases and 376 controls). Fifteen multi-dimensional clinical features were extracted. Four machine learning algorithms-Logistic Regression, Random Forest, SVM, and XGBoost-were trained and validated. Model performance was assessed via AUROC, AUPRC, and calibration curves. SHapley Additive exPlanations (SHAP) and LIME were employed to visualize global and local interpretability. Results: The XGBoost model demonstrated robust discriminative performance (AUC = 0.895, 95% CI: 0.85-0.93) and calibration compared to other algorithms. SHAP analysis identified drusen severity and lens opacity (LOCS III) as dominant ocular predictors, while C-reactive protein (CRP) and smoking were critical systemic contributors. Notably, interaction analysis revealed a non-linear synergistic effect: smoking was associated with an exponentially higher comorbidity risk in individuals aged >75 years, whereas CRP exhibited a distinct saturation threshold effect. Decision curve analysis confirmed the model's high net clinical benefit across a wide range of threshold probabilities. Conclusion: This study establishes a robust, clinically applicable risk stratification tool for cataract and AMD comorbidity. By uncovering non-linear interactions between aging, lifestyle, and inflammation, it provides valuable evidence-based support for personalized screening and preventive intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.